ID   CALM1_HUMAN             Reviewed;         149 AA.
AC   P0DP23; P02593; P62158; P70667; P99014; Q13942; Q53S29; Q61379; Q61380;
AC   Q96HK3;
DT   10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2017, sequence version 1.
DT   18-JUN-2025, entry version 59.
DE   RecName: Full=Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442};
GN   Name=CALM1 {ECO:0000303|PubMed:7925473, ECO:0000312|HGNC:HGNC:1442};
GN   Synonyms=CALM, CAM, CAM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6385987;
RA   Wawrzynczak E.J., Perham R.N.;
RT   "Isolation and nucleotide sequence of a cDNA encoding human calmodulin.";
RL   Biochem. Int. 9:177-185(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=7925473; DOI=10.1111/j.1432-1033.1994.00071.x;
RA   Rhyner J.A., Ottiger M., Wicki R., Greenwood T.M., Strehler E.E.;
RT   "Structure of the human CALM1 calmodulin gene and identification of two
RT   CALM1-related pseudogenes CALM1P1 and CALM1P2.";
RL   Eur. J. Biochem. 225:71-82(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Lung, Lymph, Placenta, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-149, ACETYLATION AT ALA-2, AND METHYLATION AT
RP   LYS-116.
RC   TISSUE=Brain;
RX   PubMed=7093203; DOI=10.1021/bi00539a041;
RA   Sasagawa T., Ericsson L.H., Walsh K.A., Schreiber W.E., Fischer E.H.,
RA   Titani K.;
RT   "Complete amino acid sequence of human brain calmodulin.";
RL   Biochemistry 21:2565-2569(1982).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-31 AND 92-107, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Osteosarcoma;
RA   Bienvenut W.V., Bensaad K., Vousden K.H.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 15-31; 77-107 AND 128-149, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   INTERACTION WITH TTN.
RX   PubMed=9804419; DOI=10.1038/27603;
RA   Mayans O., van der Ven P.F.M., Wilm M., Mues A., Young P., Furst D.O.,
RA   Wilmanns M., Gautel M.;
RT   "Structural basis for activation of the titin kinase domain during
RT   myofibrillogenesis.";
RL   Nature 395:863-869(1998).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [11]
RP   INTERACTION WITH SRY.
RX   PubMed=12871148; DOI=10.2174/0929866033479004;
RA   Kelly S., Yotis J., Macris M., Harley V.;
RT   "Recombinant expression, purification and characterisation of the HMG
RT   domain of human SRY.";
RL   Protein Pept. Lett. 10:281-286(2003).
RN   [12]
RP   INTERACTION WITH USP6.
RX   PubMed=16127172; DOI=10.1074/jbc.m505220200;
RA   Shen C., Ye Y., Robertson S.E., Lau A.W., Mak D.O., Chou M.M.;
RT   "Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific
RT   protease TRE17/USP6.";
RL   J. Biol. Chem. 280:35967-35973(2005).
RN   [13]
RP   INTERACTION WITH SRY.
RX   PubMed=15746192; DOI=10.1210/me.2004-0334;
RA   Sim H., Rimmer K., Kelly S., Ludbrook L.M., Clayton A.H., Harley V.R.;
RT   "Defective calmodulin-mediated nuclear transport of the sex-determining
RT   region of the Y chromosome (SRY) in XY sex reversal.";
RL   Mol. Endocrinol. 19:1884-1892(2005).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [15]
RP   FUNCTION, INTERACTION WITH CCP110, AND SUBCELLULAR LOCATION.
RX   PubMed=16760425; DOI=10.1091/mbc.e06-04-0371;
RA   Tsang W.Y., Spektor A., Luciano D.J., Indjeian V.B., Chen Z.,
RA   Salisbury J.L., Sanchez I., Dynlacht B.D.;
RT   "CP110 cooperates with two calcium-binding proteins to regulate cytokinesis
RT   and genome stability.";
RL   Mol. Biol. Cell 17:3423-3434(2006).
RN   [16]
RP   INTERACTION WITH CEP97 AND CCP110.
RX   PubMed=17719545; DOI=10.1016/j.cell.2007.06.027;
RA   Spektor A., Tsang W.Y., Khoo D., Dynlacht B.D.;
RT   "Cep97 and CP110 suppress a cilia assembly program.";
RL   Cell 130:678-690(2007).
RN   [17]
RP   INTERACTION WITH KCNQ1.
RX   PubMed=18165683; DOI=10.1074/jbc.m707541200;
RA   Wiener R., Haitin Y., Shamgar L., Fernandez-Alonso M.C., Martos A.,
RA   Chomsky-Hecht O., Rivas G., Attali B., Hirsch J.A.;
RT   "The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit
RT   assembly and protein interaction.";
RL   J. Biol. Chem. 283:5815-5830(2008).
RN   [18]
RP   INTERACTION WITH RYR1 AND RYR2.
RX   PubMed=18650434; DOI=10.1074/jbc.m804432200;
RA   Wright N.T., Prosser B.L., Varney K.M., Zimmer D.B., Schneider M.F.,
RA   Weber D.J.;
RT   "S100A1 and calmodulin compete for the same binding site on ryanodine
RT   receptor.";
RL   J. Biol. Chem. 283:26676-26683(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-100, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-100 AND TYR-139, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-22 AND LYS-95, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   INTERACTION WITH CDK5RAP2.
RX   PubMed=20466722; DOI=10.1074/jbc.m110.105965;
RA   Wang Z., Wu T., Shi L., Zhang L., Zheng W., Qu J.Y., Niu R., Qi R.Z.;
RT   "Conserved motif of CDK5RAP2 mediates its localization to centrosomes and
RT   the Golgi complex.";
RL   J. Biol. Chem. 285:22658-22665(2010).
RN   [24]
RP   INTERACTION WITH RUBELLA VIRUS PROTEASE/METHYLTRANSFERASE P150.
RX   PubMed=20086014; DOI=10.1074/jbc.m109.097063;
RA   Zhou Y., Tzeng W.P., Wong H.C., Ye Y., Jiang J., Chen Y., Huang Y.,
RA   Suppiah S., Frey T.K., Yang J.J.;
RT   "Calcium-dependent association of calmodulin with the rubella virus
RT   nonstructural protease domain.";
RL   J. Biol. Chem. 285:8855-8868(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [27]
RP   INTERACTION WITH ORAI1.
RX   PubMed=23109337; DOI=10.1074/jbc.m112.380964;
RA   Liu Y., Zheng X., Mueller G.A., Sobhany M., DeRose E.F., Zhang Y.,
RA   London R.E., Birnbaumer L.;
RT   "Crystal structure of calmodulin binding domain of orai1 in complex with
RT   Ca2+ calmodulin displays a unique binding mode.";
RL   J. Biol. Chem. 287:43030-43041(2012).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [29]
RP   INTERACTION WITH FCHO1.
RX   PubMed=22484487; DOI=10.1038/ncb2473;
RA   Umasankar P.K., Sanker S., Thieman J.R., Chakraborty S., Wendland B.,
RA   Tsang M., Traub L.M.;
RT   "Distinct and separable activities of the endocytic clathrin-coat
RT   components Fcho1/2 and AP-2 in developmental patterning.";
RL   Nat. Cell Biol. 14:488-501(2012).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND SER-102, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102 AND THR-111, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [33]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-116, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [34]
RP   IDENTIFICATION IN THE SIFI COMPLEX.
RX   PubMed=25582440; DOI=10.1074/mcp.m114.042168;
RA   Hong J.H., Kaustov L., Coyaud E., Srikumar T., Wan J., Arrowsmith C.,
RA   Raught B.;
RT   "KCMF1 (potassium channel modulatory factor 1) Links RAD6 to UBR4
RT   (ubiquitin N-recognin domain-containing E3 ligase 4) and lysosome-mediated
RT   degradation.";
RL   Mol. Cell. Proteomics 14:674-685(2015).
RN   [35]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [36]
RP   FUNCTION, AND INTERACTION WITH PIK3C3.
RX   PubMed=28890335; DOI=10.1016/j.molcel.2017.08.005;
RA   Zhao Y.G., Chen Y., Miao G., Zhao H., Qu W., Li D., Wang Z., Liu N., Li L.,
RA   Chen S., Liu P., Feng D., Zhang H.;
RT   "The ER-Localized Transmembrane Protein EPG-3/VMP1 Regulates SERCA Activity
RT   to Control ER-Isolation Membrane Contacts for Autophagosome Formation.";
RL   Mol. Cell 67:974.e6-989.e6(2017).
RN   [37]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-22, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [38]
RP   INTERACTION WITH KIF1A.
RX   PubMed=30021165; DOI=10.1016/j.celrep.2018.06.071;
RA   Stucchi R., Plucinska G., Hummel J.J.A., Zahavi E.E., Guerra San Juan I.,
RA   Klykov O., Scheltema R.A., Altelaar A.F.M., Hoogenraad C.C.;
RT   "Regulation of KIF1A-Driven Dense Core Vesicle Transport: Ca2+/CaM Controls
RT   DCV Binding and Liprin-alpha/TANC2 Recruits DCVs to Postsynaptic Sites.";
RL   Cell Rep. 24:685-700(2018).
RN   [39]
RP   INTERACTION WITH SLC9A1.
RX   PubMed=30287853; DOI=10.1038/s41598-018-33096-5;
RA   Fuchs S., Hansen S.C., Markones M., Mymrikov E.V., Heerklotz H., Hunte C.;
RT   "Calcineurin B homologous protein 3 binds with high affinity to the CHP
RT   binding domain of the human sodium/proton exchanger NHE1.";
RL   Sci. Rep. 8:14837-14837(2018).
RN   [40]
RP   INTERACTION WITH KCNN3.
RX   PubMed=31155282; DOI=10.1016/j.ajhg.2019.04.012;
RA   Bauer C.K., Schneeberger P.E., Kortuem F., Altmueller J.,
RA   Santos-Simarro F., Baker L., Keller-Ramey J., White S.M., Campeau P.M.,
RA   Gripp K.W., Kutsche K.;
RT   "Gain-of-function mutations in KCNN3 encoding the small-conductance Ca2+-
RT   activated K+ channel SK3 cause Zimmermann-Laband syndrome.";
RL   Am. J. Hum. Genet. 104:1139-1157(2019).
RN   [41]
RP   INTERACTION WITH LEGIONELLA PNEUMOPHILA SIDJ (MICROBIAL INFECTION), AND
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=31330532; DOI=10.1038/s41586-019-1440-8;
RA   Bhogaraju S., Bonn F., Mukherjee R., Adams M., Pfleiderer M.M., Galej W.P.,
RA   Matkovic V., Lopez-Mosqueda J., Kalayil S., Shin D., Dikic I.;
RT   "Inhibition of bacterial ubiquitin ligases by SidJ-calmodulin catalysed
RT   glutamylation.";
RL   Nature 572:382-386(2019).
RN   [42]
RP   INTERACTION WITH SLC26A5.
RX   PubMed=33667636; DOI=10.1016/j.jsb.2021.107714;
RA   Costanzi E., Coletti A., Zambelli B., Macchiarulo A., Bellanda M.,
RA   Battistutta R.;
RT   "Calmodulin binds to the STAS domain of SLC26A5 prestin with a calcium-
RT   dependent, one-lobe, binding mode.";
RL   J. Struct. Biol. 213:107714-107714(2021).
RN   [43]
RP   INTERACTION WITH C.VIOLACEUM COPC TOXIN (MICROBIAL INFECTION), AND FUNCTION
RP   (MICROBIAL INFECTION).
RX   PubMed=35338844; DOI=10.1016/j.molcel.2022.03.010;
RA   Peng T., Tao X., Xia Z., Hu S., Xue J., Zhu Q., Pan X., Zhang Q., Li S.;
RT   "Pathogen hijacks programmed cell death signaling by arginine ADPR-
RT   deacylization of caspases.";
RL   Mol. Cell 82:1806-1820(2022).
RN   [44]
RP   INTERACTION WITH C.VIOLACEUM COPC TOXIN (MICROBIAL INFECTION), AND FUNCTION
RP   (MICROBIAL INFECTION).
RX   PubMed=35446120; DOI=10.1128/mbio.00690-22;
RA   Liu Y., Zeng H., Hou Y., Li Z., Li L., Song X., Ding J., Shao F., Xu Y.;
RT   "Calmodulin binding activates chromobacterium CopC effector to ADP-
RT   riboxanate host apoptotic caspases.";
RL   MBio 0:0-0(2022).
RN   [45]
RP   FUNCTION, ACTIVITY REGULATION (MICROBIAL INFECTION), AND INTERACTION WITH
RP   S.FLEXNERI OSPC1 AND OSPC3 (MICROBIAL INFECTION).
RX   PubMed=35568036; DOI=10.1016/j.cell.2022.04.028;
RA   Alphonse N., Wanford J.J., Voak A.A., Gay J., Venkhaya S., Burroughs O.,
RA   Mathew S., Lee T., Evans S.L., Zhao W., Frowde K., Alrehaili A.,
RA   Dickenson R.E., Munk M., Panina S., Mahmood I.F., Llorian M.,
RA   Stanifer M.L., Boulant S., Berchtold M.W., Bergeron J.R.C., Wack A.,
RA   Lesser C.F., Odendall C.;
RT   "A family of conserved bacterial virulence factors dampens interferon
RT   responses by blocking calcium signaling.";
RL   Cell 185:2354-2369(2022).
RN   [46]
RP   IDENTIFICATION IN THE SIFI COMPLEX.
RX   PubMed=38297121; DOI=10.1038/s41586-023-06985-7;
RA   Haakonsen D.L., Heider M., Ingersoll A.J., Vodehnal K., Witus S.R.,
RA   Uenaka T., Wernig M., Rape M.;
RT   "Stress response silencing by an E3 ligase mutated in neurodegeneration.";
RL   Nature 626:874-880(2024).
RN   [47]
RP   STRUCTURE BY NMR OF 95-104.
RX   PubMed=9927666; DOI=10.1073/pnas.96.3.903;
RA   Siedlecka M., Goch G., Ejchart A., Sticht H., Bierzyski A.;
RT   "Alpha-helix nucleation by a calcium-binding peptide loop.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:903-908(1999).
RN   [48]
RP   STRUCTURE BY NMR OF 1-77 AND 83-149.
RX   PubMed=11685248; DOI=10.1038/nsb1101-990;
RA   Chou J.J., Li S., Klee C.B., Bax A.;
RT   "Solution structure of Ca(2+)-calmodulin reveals flexible hand-like
RT   properties of its domains.";
RL   Nat. Struct. Biol. 8:990-997(2001).
RN   [49] {ECO:0007744|PDB:1CLL}
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH CALCIUM, AND
RP   CALCIUM-BINDING SITES.
RX   PubMed=1474585; DOI=10.1016/0022-2836(92)90324-d;
RA   Chattopadhyaya R., Meador W.E., Means A.R., Quiocho F.A.;
RT   "Calmodulin structure refined at 1.7 A resolution.";
RL   J. Mol. Biol. 228:1177-1192(1992).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS).
RX   PubMed=7803388; DOI=10.1021/bi00255a006;
RA   Cook W.J., Walter L.J., Walter M.R.;
RT   "Drug binding by calmodulin: crystal structure of a calmodulin-
RT   trifluoperazine complex.";
RL   Biochemistry 33:15259-15265(1994).
RN   [51]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 6-149.
RX   PubMed=11807546; DOI=10.1038/415396a;
RA   Drum C.L., Yan S.-Z., Bard J., Shen Y.-Q., Lu D., Soelaiman S.,
RA   Grabarek Z., Bohm A., Tang W.-J.;
RT   "Structural basis for the activation of anthrax adenylyl cyclase exotoxin
RT   by calmodulin.";
RL   Nature 415:396-402(2002).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (3.6 ANGSTROMS) OF 1-149 IN COMPLEX WITH ANTHRAX
RP   EDEMA FACTOR CYA.
RX   PubMed=12485993; DOI=10.1093/emboj/cdf681;
RA   Shen Y., Lee Y.-S., Soelaiman S., Bergson P., Lu D., Chen A.,
RA   Beckingham K., Grabarek Z., Mrksich M., Tang W.-J.;
RT   "Physiological calcium concentrations regulate calmodulin binding and
RT   catalysis of adenylyl cyclase exotoxins.";
RL   EMBO J. 21:6721-6732(2002).
RN   [53]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH MARCKS.
RX   PubMed=12577052; DOI=10.1038/nsb900;
RA   Yamauchi E., Nakatsu T., Matsubara M., Kato H., Taniguchi H.;
RT   "Crystal structure of a MARCKS peptide containing the calmodulin-binding
RT   domain in complex with Ca2+-calmodulin.";
RL   Nat. Struct. Biol. 10:226-231(2003).
RN   [54]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-150 IN COMPLEX WITH CACNA1C.
RX   PubMed=16299511; DOI=10.1038/nsmb1027;
RA   Van Petegem F., Chatelain F.C., Minor D.L. Jr.;
RT   "Insights into voltage-gated calcium channel regulation from the structure
RT   of the CaV1.2 IQ domain-Ca2+/calmodulin complex.";
RL   Nat. Struct. Mol. Biol. 12:1108-1115(2005).
RN   [55]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) IN COMPLEX WITH ANTHRAX EDEMA FACTOR
RP   CYA.
RX   PubMed=15719022; DOI=10.1038/sj.emboj.7600574;
RA   Shen Y., Zhukovskaya N.L., Guo Q., Florian J., Tang W.-J.;
RT   "Calcium-independent calmodulin binding and two-metal-ion catalytic
RT   mechanism of anthrax edema factor.";
RL   EMBO J. 24:929-941(2005).
RN   [56]
RP   STRUCTURE BY NMR IN COMPLEX WITH SCN5A.
RX   PubMed=21167176; DOI=10.1016/j.jmb.2010.11.046;
RA   Chagot B., Chazin W.J.;
RT   "Solution NMR structure of Apo-calmodulin in complex with the IQ motif of
RT   human cardiac sodium channel NaV1.5.";
RL   J. Mol. Biol. 406:106-119(2011).
RN   [57]
RP   STRUCTURE BY ELECTRON MICROSCOPY (25 ANGSTROMS) IN COMPLEX WITH MIP,
RP   FUNCTION, AND INTERACTION WITH MIP.
RX   PubMed=23893133; DOI=10.1038/nsmb.2630;
RA   Reichow S.L., Clemens D.M., Freites J.A., Nemeth-Cahalan K.L., Heyden M.,
RA   Tobias D.J., Hall J.E., Gonen T.;
RT   "Allosteric mechanism of water-channel gating by Ca(2+)-calmodulin.";
RL   Nat. Struct. Mol. Biol. 20:1085-1092(2013).
RN   [58] {ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C}
RP   X-RAY CRYSTALLOGRAPHY (2.86 ANGSTROMS) IN COMPLEX WITH KCNQ1 AND CALCIUM,
RP   FUNCTION, INTERACTION WITH KCNQ1, AND DOMAIN.
RX   PubMed=25441029; DOI=10.1016/j.str.2014.07.016;
RA   Sachyani D., Dvir M., Strulovich R., Tria G., Tobelaim W., Peretz A.,
RA   Pongs O., Svergun D., Attali B., Hirsch J.A.;
RT   "Structural basis of a Kv7.1 potassium channel gating module: studies of
RT   the intracellular c-terminal domain in complex with calmodulin.";
RL   Structure 22:1582-1594(2014).
RN   [59] {ECO:0007744|PDB:5J03}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH CALCIUM; KCNQ2 AND
RP   KCNQ3, INTERACTION WITH KCNQ2 AND KCNQ3, AND CALCIUM-BINDING SITES.
RX   PubMed=27564677; DOI=10.1021/acs.biochem.6b00477;
RA   Strulovich R., Tobelaim W.S., Attali B., Hirsch J.A.;
RT   "Structural insights into the M-channel proximal C-terminus/calmodulin
RT   complex.";
RL   Biochemistry 55:5353-5365(2016).
RN   [60] {ECO:0007744|PDB:2N77}
RP   STRUCTURE BY NMR OF 77-149 IN COMPLEX WITH PCP4, INTERACTION WITH PCP4, AND
RP   REGION.
RX   PubMed=27876793; DOI=10.1038/ncomms13583;
RA   Wang X., Putkey J.A.;
RT   "PEP-19 modulates calcium binding to calmodulin by electrostatic
RT   steering.";
RL   Nat. Commun. 7:13583-13583(2016).
RN   [61]
RP   STRUCTURE BY NMR, AND INTERACTION WITH ALPHA-SYNUCLEIN/SNCA.
RX   PubMed=23607618; DOI=10.1021/bi400199p;
RA   Gruschus J.M., Yap T.L., Pistolesi S., Maltsev A.S., Lee J.C.;
RT   "NMR structure of calmodulin complexed to an N-terminally acetylated alpha-
RT   synuclein peptide.";
RL   Biochemistry 52:3436-3445(2013).
RN   [62] {ECO:0007744|PDB:6CNM, ECO:0007744|PDB:6CNN, ECO:0007744|PDB:6CNO}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.40 ANGSTROMS) IN COMPLEX WITH KCNN4 AND
RP   CALCIUM, SUBUNIT, AND DOMAIN.
RX   PubMed=29724949; DOI=10.1126/science.aas9466;
RA   Lee C.H., MacKinnon R.;
RT   "Activation mechanism of a human SK-calmodulin channel complex elucidated
RT   by cryo-EM structures.";
RL   Science 360:508-513(2018).
RN   [63]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.18 ANGSTROMS) IN COMPLEX WITH
RP   C.VIOLACEUM COPC AND CASP3, INTERACTION WITH C.VIOLACEUM COPC TOXIN
RP   (MICROBIAL INFECTION), AND FUNCTION (MICROBIAL INFECTION).
RX   PubMed=36423631; DOI=10.1016/j.molcel.2022.10.032;
RA   Zhang K., Peng T., Tao X., Tian M., Li Y., Wang Z., Ma S., Hu S., Pan X.,
RA   Xue J., Luo J., Wu Q., Fu Y., Li S.;
RT   "Structural insights into caspase ADPR deacylization catalyzed by a
RT   bacterial effector and host calmodulin.";
RL   Mol. Cell 0:0-0(2022).
RN   [64] {ECO:0007744|PDB:7WR4, ECO:0007744|PDB:7WR5}
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 102-377 IN COMPLEX WITH CASP4 AND
RP   S.FLEXNERI OSPC3, FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH
RP   S.FLEXNERI OSPC3 (MICROBIAL INFECTION).
RX   PubMed=36624349; DOI=10.1038/s41594-022-00888-3;
RA   Hou Y., Zeng H., Li Z., Feng N., Meng F., Xu Y., Li L., Shao F., Ding J.;
RT   "Structural mechanisms of calmodulin activation of Shigella effector OspC3
RT   to ADP-riboxanate caspase-4/11 and block pyroptosis.";
RL   Nat. Struct. Mol. Biol. 30:261-272(2023).
RN   [65]
RP   INVOLVEMENT IN CPVT4, VARIANTS CPVT4 ILE-54 AND SER-98, AND
RP   CHARACTERIZATION OF VARIANTS CPVT4 ILE-54 AND SER-98.
RX   PubMed=23040497; DOI=10.1016/j.ajhg.2012.08.015;
RA   Nyegaard M., Overgaard M.T., Sondergaard M.T., Vranas M., Behr E.R.,
RA   Hildebrandt L.L., Lund J., Hedley P.L., Camm A.J., Wettrell G., Fosdal I.,
RA   Christiansen M., Borglum A.D.;
RT   "Mutations in calmodulin cause ventricular tachycardia and sudden cardiac
RT   death.";
RL   Am. J. Hum. Genet. 91:703-712(2012).
RN   [66]
RP   INVOLVEMENT IN LQT14, VARIANTS LQT14 GLY-130 AND LEU-142, AND
RP   CHARACTERIZATION OF VARIANTS LQT14 GLY-130 AND LEU-142.
RX   PubMed=23388215; DOI=10.1161/circulationaha.112.001216;
RA   Crotti L., Johnson C.N., Graf E., De Ferrari G.M., Cuneo B.F., Ovadia M.,
RA   Papagiannis J., Feldkamp M.D., Rathi S.G., Kunic J.D., Pedrazzini M.,
RA   Wieland T., Lichtner P., Beckmann B.M., Clark T., Shaffer C., Benson D.W.,
RA   Kaab S., Meitinger T., Strom T.M., Chazin W.J., Schwartz P.J.,
RA   George A.L. Jr.;
RT   "Calmodulin mutations associated with recurrent cardiac arrest in
RT   infants.";
RL   Circulation 127:1009-1017(2013).
RN   [67]
RP   CHARACTERIZATION OF VARIANT LQT14 LEU-90.
RX   PubMed=25036739; DOI=10.1016/j.febslet.2014.07.007;
RA   Nomikos M., Thanassoulas A., Beck K., Vassilakopoulou V., Hu H.,
RA   Calver B.L., Theodoridou M., Kashir J., Blayney L., Livaniou E.,
RA   Rizkallah P., Nounesis G., Lai F.A.;
RT   "Altered RyR2 regulation by the calmodulin F90L mutation associated with
RT   idiopathic ventricular fibrillation and early sudden cardiac death.";
RL   FEBS Lett. 588:2898-2902(2014).
RN   [68]
RP   INVOLVEMENT IN LQT14, AND VARIANT LQT14 LEU-90.
RX   PubMed=24076290; DOI=10.1016/j.jacc.2013.07.091;
RA   Marsman R.F., Barc J., Beekman L., Alders M., Dooijes D.,
RA   van den Wijngaard A., Ratbi I., Sefiani A., Bhuiyan Z.A., Wilde A.A.,
RA   Bezzina C.R.;
RT   "A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular
RT   fibrillation in childhood and adolescence.";
RL   J. Am. Coll. Cardiol. 63:259-266(2014).
RN   [69]
RP   VARIANTS CPVT4 ILE-54 AND SER-98, CHARACTERIZATION OF VARIANTS CPVT4 ILE-54
RP   AND SER-98, VARIANTS LQT14 GLY-130 AND LEU-142, CHARACTERIZATION OF
RP   VARIANTS LQT14 GLY-130 AND LEU-142, AND INTERACTION WITH RYR2.
RX   PubMed=26164367; DOI=10.1016/j.bbagen.2015.07.001;
RA   Vassilakopoulou V., Calver B.L., Thanassoulas A., Beck K., Hu H.,
RA   Buntwal L., Smith A., Theodoridou M., Kashir J., Blayney L., Livaniou E.,
RA   Nounesis G., Lai F.A., Nomikos M.;
RT   "Distinctive malfunctions of calmodulin mutations associated with heart
RT   RyR2-mediated arrhythmic disease.";
RL   Biochim. Biophys. Acta 1850:2168-2176(2015).
RN   [70]
RP   VARIANTS CPVT4 ILE-54 AND SER-98, CHARACTERIZATION OF VARIANTS CPVT4
RP   ILE-54; SER-98, AND INTERACTION WITH RYR2.
RX   PubMed=27516456; DOI=10.1161/circep.116.004161;
RA   Gomez-Hurtado N., Boczek N.J., Kryshtal D.O., Johnson C.N., Sun J.,
RA   Nitu F.R., Cornea R.L., Chazin W.J., Calvert M.L., Tester D.J.,
RA   Ackerman M.J., Knollmann B.C.;
RT   "Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates
RT   Arrhythmogenic Ca Waves and Sparks.";
RL   Circ. Arrhythm. Electrophysiol. 9:0-0(2016).
RN   [71]
RP   VARIANTS LQT14 GLY-141 AND LEU-142, CHARACTERIZATION OF VARIANT LQT14
RP   GLY-141, AND FUNCTION.
RX   PubMed=26969752; DOI=10.1161/circgenetics.115.001323;
RA   Boczek N.J., Gomez-Hurtado N., Ye D., Calvert M.L., Tester D.J.,
RA   Kryshtal D.O., Hwang H.S., Johnson C.N., Chazin W.J., Loporcaro C.G.,
RA   Shah M., Papez A.L., Lau Y.R., Kanter R., Knollmann B.C., Ackerman M.J.;
RT   "Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin
RT   Variants in Long QT Syndrome and Functional Characterization of a Novel
RT   Long QT Syndrome-Associated Calmodulin Missense Variant, E141G.";
RL   Circ. Cardiovasc. Genet. 9:136-146(2016).
RN   [72]
RP   VARIANTS CPVT4 ILE-54 AND SER-98, CHARACTERIZATION OF VARIANTS CPVT4 ILE-54
RP   AND SER-98, VARIANTS LQT14 LEU-90 AND GLY-130, CHARACTERIZATION OF VARIANTS
RP   LQT14 LEU-90 AND GLY-130, AND FUNCTION.
RX   PubMed=27165696; DOI=10.1016/j.hrthm.2016.05.009;
RA   Yu C.C., Ko J.S., Ai T., Tsai W.C., Chen Z., Rubart M., Vatta M.,
RA   Everett T.H. IV, George A.L. Jr., Chen P.S.;
RT   "Arrhythmogenic calmodulin mutations impede activation of small-conductance
RT   calcium-activated potassium current.";
RL   Heart Rhythm 13:1716-1723(2016).
RN   [73]
RP   CHARACTERIZATION OF VARIANT LQT14 LEU-142.
RX   PubMed=28158429; DOI=10.1093/cvr/cvx006;
RA   Rocchetti M., Sala L., Dreizehnter L., Crotti L., Sinnecker D., Mura M.,
RA   Pane L.S., Altomare C., Torre E., Mostacciuolo G., Severi S., Porta A.,
RA   De Ferrari G.M., George A.L. Jr., Schwartz P.J., Gnecchi M., Moretti A.,
RA   Zaza A.;
RT   "Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L
RT   mutation in patient-specific induced pluripotent stem cell-derived
RT   cardiomyocytes.";
RL   Cardiovasc. Res. 113:531-541(2017).
RN   [74]
RP   VARIANT LQT14 VAL-141, CHARACTERIZATION OF VARIANT LQT14 VAL-141, AND
RP   FUNCTION.
RX   PubMed=31454269; DOI=10.1161/circgen.119.002581;
RA   Wren L.M., Jimenez-Jaimez J., Al-Ghamdi S., Al-Aama J.Y., Bdeir A.,
RA   Al-Hassnan Z.N., Kuan J.L., Foo R.Y., Potet F., Johnson C.N., Aziz M.C.,
RA   Carvill G.L., Kaski J.P., Crotti L., Perin F., Monserrat L., Burridge P.W.,
RA   Schwartz P.J., Chazin W.J., Bhuiyan Z.A., George A.L. Jr.;
RT   "Genetic mosaicism in calmodulinopathy.";
RL   Circ. Genom. Precis. Med. 12:375-385(2019).
CC   -!- FUNCTION: Calmodulin acts as part of a calcium signal transduction
CC       pathway by mediating the control of a large number of enzymes, ion
CC       channels, aquaporins and other proteins through calcium-binding
CC       (PubMed:16760425, PubMed:23893133, PubMed:26969752, PubMed:27165696,
CC       PubMed:28890335, PubMed:31454269, PubMed:35568036). Calcium-binding is
CC       required for the activation of calmodulin (PubMed:16760425,
CC       PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335,
CC       PubMed:31454269, PubMed:35568036). Among the enzymes to be stimulated
CC       by the calmodulin-calcium complex are a number of protein kinases, such
CC       as myosin light-chain kinases and calmodulin-dependent protein kinase
CC       type II (CaMK2), and phosphatases (PubMed:16760425, PubMed:23893133,
CC       PubMed:26969752, PubMed:27165696, PubMed:28890335, PubMed:31454269,
CC       PubMed:35568036). Together with CCP110 and centrin, is involved in a
CC       genetic pathway that regulates the centrosome cycle and progression
CC       through cytokinesis (PubMed:16760425). Is a regulator of voltage-
CC       dependent L-type calcium channels (PubMed:31454269). Mediates calcium-
CC       dependent inactivation of CACNA1C (PubMed:26969752). Positively
CC       regulates calcium-activated potassium channel activity of KCNN2
CC       (PubMed:27165696). Forms a potassium channel complex with KCNQ1 and
CC       regulates electrophysiological activity of the channel via calcium-
CC       binding (PubMed:25441029). Acts as a sensor to modulate the endoplasmic
CC       reticulum contacts with other organelles mediated by VMP1:ATP2A2
CC       (PubMed:28890335). {ECO:0000269|PubMed:16760425,
CC       ECO:0000269|PubMed:23893133, ECO:0000269|PubMed:25441029,
CC       ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696,
CC       ECO:0000269|PubMed:28890335, ECO:0000269|PubMed:31454269,
CC       ECO:0000269|PubMed:35568036}.
CC   -!- FUNCTION: (Microbial infection) Required for Legionella pneumophila
CC       SidJ glutamylase activity. {ECO:0000269|PubMed:31330532}.
CC   -!- FUNCTION: (Microbial infection) Required for C.violaceum CopC and
CC       S.flexneri OspC3 arginine ADP-riboxanase activity.
CC       {ECO:0000269|PubMed:35338844, ECO:0000269|PubMed:35446120,
CC       ECO:0000269|PubMed:36423631, ECO:0000269|PubMed:36624349}.
CC   -!- ACTIVITY REGULATION: (Microbial infection) Inactivated by S.flexneri
CC       OspC1 and OspC3 proteins, which specifically bind the apo-form of
CC       calmodulin, thereby preventing calcium-binding and activity.
CC       {ECO:0000269|PubMed:35568036}.
CC   -!- SUBUNIT: Homotetramer (PubMed:29724949). Interacts with MYO1C, MYO5A
CC       and RRAD. Interacts with MYO10 (By similarity). Interacts with CEP97,
CC       CCP110, TTN/titin and SRY (PubMed:12871148, PubMed:15746192,
CC       PubMed:16760425, PubMed:17719545, PubMed:9804419). Interacts with USP6;
CC       the interaction is calcium dependent (PubMed:16127172). Interacts with
CC       CDK5RAP2 (PubMed:20466722). Interacts with SCN5A (PubMed:21167176).
CC       Interacts with RYR1 (PubMed:18650434). Interacts with FCHO1
CC       (PubMed:22484487). Interacts with MIP in a 1:2 stoichiometry; the
CC       interaction with the cytoplasmic domains from two MIP subunits promotes
CC       MIP water channel closure (PubMed:23893133). Interacts with ORAI1; this
CC       may play a role in the regulation of ORAI1-mediated calcium transport
CC       (By similarity). Interacts with IQCF1 (By similarity). Interacts with
CC       SYT7 (By similarity). Interacts with CEACAM1 (via cytoplasmic domain);
CC       this interaction is in a calcium dependent manner and reduces
CC       homophilic cell adhesion through dissociation of dimer (By similarity).
CC       Interacts with RYR2; regulates RYR2 calcium-release channel activity
CC       (PubMed:18650434, PubMed:26164367, PubMed:27516456). Interacts with
CC       PCP4; regulates calmodulin calcium-binding (PubMed:27876793). Interacts
CC       with the heterotetrameric KCNQ2 and KCNQ3 channel; the interaction is
CC       calcium-independent, constitutive and participates in the proper
CC       assembly of a functional heterotetrameric M channel (PubMed:27564677).
CC       Interacts with alpha-synuclein/SNCA (PubMed:23607618). Interacts with
CC       SLC9A1 in a calcium-dependent manner (PubMed:30287853). In the absence
CC       of Ca(+2), interacts with GIMAP4 (via IQ domain) (By similarity).
CC       Interacts with SCN8A; the interaction modulates the inactivation rate
CC       of SCN8A (By similarity). Interaction with KIF1A; the interaction is
CC       increased in presence of calcium and increases neuronal dense core
CC       vesicles motility (PubMed:30021165). Interacts with KCNN3
CC       (PubMed:31155282). Interacts with KCNQ1 (via C-terminus); forms a
CC       heterooctameric structure (with 4:4 KCNQ1:CALM stoichiometry) in a
CC       calcium-independent manner (PubMed:18165683, PubMed:25441029).
CC       Interacts with PIK3C3; the interaction modulates PIK3C3 kinase activity
CC       (PubMed:28890335). Interacts with HINT1; interaction increases in the
CC       presence of calcium ions (By similarity). Interacts with HINT3 (By
CC       similarity). Interacts with GARIN2; in mature sperm flagella (By
CC       similarity). Interacts with IQUB (By similarity). Interacts with
CC       SLC26A5 (via STAS domain); this interaction is calcium-dependent and
CC       the STAS domain interacts with only one lobe of CALM which is an
CC       elongated conformation (PubMed:33667636). Ca(2+)-bound CALM1 binds
CC       CNGA1:CNGB1 channel (via CaM1 and CaM2 regions); this interaction
CC       modulates the affinity of the channel for cNMPs in response to
CC       intracellular Ca(2+) levels. Interacts with ITPR1; this interaction
CC       inhibits inositol 1,4,5 trisphosphate binding in both the presence and
CC       absence of calcium and 1,4,5 trisphosphate-induced calcium release in
CC       the presence of calcium (By similarity). Component of the SIFI complex
CC       (PubMed:25582440, PubMed:38297121). Interacts with KCNN4; this
CC       interaction allows channel opening (PubMed:29724949). Interacts with
CC       KCNN2; this interaction regulates the channel activity through calcium-
CC       binding (By similarity). {ECO:0000250|UniProtKB:P0DP26,
CC       ECO:0000250|UniProtKB:P0DP29, ECO:0000250|UniProtKB:P62157,
CC       ECO:0000250|UniProtKB:P62161, ECO:0000250|UniProtKB:P62204,
CC       ECO:0000269|PubMed:12485993, ECO:0000269|PubMed:12577052,
CC       ECO:0000269|PubMed:12871148, ECO:0000269|PubMed:15719022,
CC       ECO:0000269|PubMed:15746192, ECO:0000269|PubMed:16127172,
CC       ECO:0000269|PubMed:16299511, ECO:0000269|PubMed:16760425,
CC       ECO:0000269|PubMed:17719545, ECO:0000269|PubMed:18165683,
CC       ECO:0000269|PubMed:18650434, ECO:0000269|PubMed:20466722,
CC       ECO:0000269|PubMed:21167176, ECO:0000269|PubMed:22484487,
CC       ECO:0000269|PubMed:23109337, ECO:0000269|PubMed:23607618,
CC       ECO:0000269|PubMed:23893133, ECO:0000269|PubMed:25441029,
CC       ECO:0000269|PubMed:25582440, ECO:0000269|PubMed:26164367,
CC       ECO:0000269|PubMed:27516456, ECO:0000269|PubMed:27564677,
CC       ECO:0000269|PubMed:27876793, ECO:0000269|PubMed:28890335,
CC       ECO:0000269|PubMed:29724949, ECO:0000269|PubMed:30021165,
CC       ECO:0000269|PubMed:30287853, ECO:0000269|PubMed:31155282,
CC       ECO:0000269|PubMed:33667636, ECO:0000269|PubMed:38297121,
CC       ECO:0000269|PubMed:9804419}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Rubella virus
CC       protease/methyltransferase p150. {ECO:0000269|PubMed:20086014}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Legionella pneumophila
CC       glutamylase SidJ. {ECO:0000269|PubMed:31330532}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with C.violaceum CopC
CC       (PubMed:35338844, PubMed:35446120, PubMed:36423631). C.violaceum CopC
CC       interacts specifically with the apo form of calmodulin
CC       (PubMed:35446120, PubMed:36423631). {ECO:0000269|PubMed:35338844,
CC       ECO:0000269|PubMed:35446120, ECO:0000269|PubMed:36423631}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with S.flexneri OspC1 and
CC       OspC3 (PubMed:35568036, PubMed:36624349). S.flexneri OspC1 and OspC3
CC       interact specifically with the apo form of calmodulin and prevents
CC       calcium-binding (PubMed:35568036). {ECO:0000269|PubMed:35568036,
CC       ECO:0000269|PubMed:36624349}.
CC   -!- INTERACTION:
CC       P0DP23; O75874: IDH1; NbExp=7; IntAct=EBI-25817233, EBI-715695;
CC       P0DP23; Q5JU85: IQSEC2; NbExp=2; IntAct=EBI-25817233, EBI-11028607;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:16760425}. Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000269|PubMed:16760425}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:14654843}. Cell
CC       projection, cilium, flagellum {ECO:0000250|UniProtKB:P0DP26}.
CC       Note=Distributed throughout the cell during interphase, but during
CC       mitosis becomes dramatically localized to the spindle poles and the
CC       spindle microtubules.
CC   -!- DOMAIN: The N-terminal and C-terminal lobes of CALM bind to the C-
CC       terminus of KCNQ1 in a clamp-like conformation. Binding of CALM C-
CC       terminus to KCNQ1 is calcium-independent but is essential for assembly
CC       of the structure. Binding of CALM N-terminus to KCNQ1 is calcium-
CC       dependent and regulates electrophysiological activity of the channel
CC       (PubMed:25441029). The C-lobe interacts with KCNN4 channels in a
CC       calcium-independent manner, whereas the N-lobe interacts with the S4-S5
CC       linker of KCNN4 in a calcium-dependent manner playing a role as calcium
CC       sensor and gating the channel (PubMed:29724949).
CC       {ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:29724949}.
CC   -!- PTM: Ubiquitination results in a strongly decreased activity.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation results in a decreased activity. {ECO:0000250}.
CC   -!- DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 4
CC       (CPVT4) [MIM:614916]: An arrhythmogenic disorder characterized by
CC       stress-induced, bidirectional ventricular tachycardia that may
CC       degenerate into cardiac arrest and cause sudden death. Patients present
CC       with recurrent syncope, seizures, or sudden death after physical
CC       activity or emotional stress. CPVT4 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:23040497, ECO:0000269|PubMed:26164367,
CC       ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:27516456}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry. Mutations in CALM1 are the cause of CPVT4.
CC   -!- DISEASE: Long QT syndrome 14 (LQT14) [MIM:616247]: A form of long QT
CC       syndrome, a heart disorder characterized by a prolonged QT interval on
CC       the ECG and polymorphic ventricular arrhythmias. They cause syncope and
CC       sudden death in response to exercise or emotional stress, and can
CC       present with a sentinel event of sudden cardiac death in infancy.
CC       {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:24076290,
CC       ECO:0000269|PubMed:25036739, ECO:0000269|PubMed:26164367,
CC       ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696,
CC       ECO:0000269|PubMed:28158429, ECO:0000269|PubMed:31454269}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- MISCELLANEOUS: This protein has four functional calcium-binding sites.
CC       {ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677}.
CC   -!- SIMILARITY: Belongs to the calmodulin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=A question of length - Issue
CC       105 of May 2009;
CC       URL="https://www.proteinspotlight.org/back_issues/105";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M27319; AAA35635.1; -; mRNA.
DR   EMBL; U12022; AAB60644.1; -; Genomic_DNA.
DR   EMBL; U11886; AAB60644.1; JOINED; Genomic_DNA.
DR   EMBL; BT006818; AAP35464.1; -; mRNA.
DR   EMBL; AC006536; AAD45181.1; -; Genomic_DNA.
DR   EMBL; AL512791; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000454; AAH00454.1; -; mRNA.
DR   EMBL; BC008597; AAH08597.1; -; mRNA.
DR   EMBL; BC011834; AAH11834.1; -; mRNA.
DR   EMBL; BC047523; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS9892.1; -.
DR   PIR; S48728; MCHU.
DR   RefSeq; NP_001316851.1; NM_001329922.1.
DR   RefSeq; NP_001734.1; NM_001743.5.
DR   RefSeq; NP_005175.2; NM_005184.3.
DR   RefSeq; NP_008819.1; NM_006888.6.
DR   PDB; 1CDL; X-ray; 2.00 A; A/B/C/D=2-148.
DR   PDB; 1CLL; X-ray; 1.70 A; A=2-149.
DR   PDB; 1CTR; X-ray; 2.45 A; A=2-149.
DR   PDB; 1IWQ; X-ray; 2.00 A; A=2-149.
DR   PDB; 1J7O; NMR; -; A=2-77.
DR   PDB; 1J7P; NMR; -; A=83-149.
DR   PDB; 1K90; X-ray; 2.75 A; D/E/F=2-149.
DR   PDB; 1K93; X-ray; 2.95 A; D/E/F=6-149.
DR   PDB; 1L7Z; X-ray; 2.30 A; A=2-149.
DR   PDB; 1LVC; X-ray; 3.60 A; D/E/F=1-149.
DR   PDB; 1NKF; NMR; -; A=94-105.
DR   PDB; 1PK0; X-ray; 3.30 A; D/E/F=2-148.
DR   PDB; 1S26; X-ray; 3.00 A; D/E/F=2-149.
DR   PDB; 1SK6; X-ray; 3.20 A; D/E/F=2-149.
DR   PDB; 1SW8; NMR; -; A=2-80.
DR   PDB; 1UP5; X-ray; 1.90 A; A/B=2-149.
DR   PDB; 1WRZ; X-ray; 2.00 A; A=1-149.
DR   PDB; 1XFU; X-ray; 3.35 A; O/P/Q/R/S/T=1-149.
DR   PDB; 1XFV; X-ray; 3.35 A; O/P/Q/R/S/T=1-149.
DR   PDB; 1XFW; X-ray; 3.40 A; O/P/Q/R/S/T=1-149.
DR   PDB; 1XFX; X-ray; 3.20 A; O/P/Q/R/S/T=1-149.
DR   PDB; 1XFY; X-ray; 3.30 A; O/P/Q/R/S/T=1-149.
DR   PDB; 1XFZ; X-ray; 3.25 A; O/P/Q/R/S/T=1-149.
DR   PDB; 1Y6W; X-ray; 2.40 A; A=2-149.
DR   PDB; 1YR5; X-ray; 1.70 A; A=2-149.
DR   PDB; 1YRT; X-ray; 2.10 A; B=76-149.
DR   PDB; 1YRU; X-ray; 2.50 A; B=76-149.
DR   PDB; 1ZOT; X-ray; 2.20 A; B=80-148.
DR   PDB; 1ZUZ; X-ray; 1.91 A; A=1-149.
DR   PDB; 2BE6; X-ray; 2.00 A; A/B/C=1-149.
DR   PDB; 2F3Y; X-ray; 1.45 A; A=2-149.
DR   PDB; 2F3Z; X-ray; 1.60 A; A=2-149.
DR   PDB; 2HF5; NMR; -; A=47-114.
DR   PDB; 2I08; X-ray; 2.00 A; A=3-79.
DR   PDB; 2JZI; NMR; -; A=2-149.
DR   PDB; 2K0E; NMR; -; A=2-149.
DR   PDB; 2K0F; NMR; -; A=2-149.
DR   PDB; 2K0J; NMR; -; A=3-149.
DR   PDB; 2K61; NMR; -; A=2-149.
DR   PDB; 2KNE; NMR; -; A=2-149.
DR   PDB; 2KUG; NMR; -; A=2-77.
DR   PDB; 2KUH; NMR; -; A=83-149.
DR   PDB; 2L53; NMR; -; A=2-149.
DR   PDB; 2L7L; NMR; -; A=2-149.
DR   PDB; 2LGF; NMR; -; A=3-149.
DR   PDB; 2LL6; NMR; -; A=2-149.
DR   PDB; 2LL7; NMR; -; A=2-149.
DR   PDB; 2LQC; NMR; -; A=2-78.
DR   PDB; 2LQP; NMR; -; A=79-149.
DR   PDB; 2LV6; Other; -; A=2-149.
DR   PDB; 2M0J; NMR; -; A=2-149.
DR   PDB; 2M0K; NMR; -; A=2-149.
DR   PDB; 2M55; NMR; -; A=2-149.
DR   PDB; 2MG5; NMR; -; A=2-149.
DR   PDB; 2N27; NMR; -; A=2-149.
DR   PDB; 2N6A; NMR; -; A=6-147.
DR   PDB; 2N77; NMR; -; A=77-149.
DR   PDB; 2N8J; NMR; -; A=2-149.
DR   PDB; 2R28; X-ray; 1.86 A; A/B=1-149.
DR   PDB; 2V01; X-ray; 2.15 A; A=2-149.
DR   PDB; 2V02; X-ray; 2.20 A; A=2-149.
DR   PDB; 2VAY; X-ray; 1.94 A; A=4-149.
DR   PDB; 2W73; X-ray; 1.45 A; A/B/E/F=1-149.
DR   PDB; 2WEL; X-ray; 1.90 A; D=1-149.
DR   PDB; 2X0G; X-ray; 2.20 A; B=2-149.
DR   PDB; 2Y4V; X-ray; 1.80 A; A=1-149.
DR   PDB; 3BYA; X-ray; 1.85 A; A=2-149.
DR   PDB; 3DVE; X-ray; 2.35 A; A=2-149.
DR   PDB; 3DVJ; X-ray; 2.80 A; A=2-149.
DR   PDB; 3DVK; X-ray; 2.30 A; A=2-149.
DR   PDB; 3DVM; X-ray; 2.60 A; A=2-149.
DR   PDB; 3EVV; X-ray; 2.60 A; A=5-149.
DR   PDB; 3EWT; X-ray; 2.40 A; A=2-149.
DR   PDB; 3EWV; X-ray; 2.60 A; A=2-149.
DR   PDB; 3G43; X-ray; 2.10 A; A/B/C/D=2-149.
DR   PDB; 3HR4; X-ray; 2.50 A; B/D/F/H=1-149.
DR   PDB; 3J41; EM; 25.00 A; E/F=1-149.
DR   PDB; 3O77; X-ray; 2.35 A; A=1-149.
DR   PDB; 3O78; X-ray; 2.60 A; A/B=1-149.
DR   PDB; 3OXQ; X-ray; 2.55 A; A/B/C/D=1-149.
DR   PDB; 3SUI; X-ray; 1.95 A; A=1-149.
DR   PDB; 3UCT; X-ray; 1.90 A; A/B=2-80.
DR   PDB; 3UCW; X-ray; 1.76 A; A/B/C/D=2-80.
DR   PDB; 3UCY; X-ray; 1.80 A; A=2-80.
DR   PDB; 4BW7; X-ray; 1.81 A; A/C=1-149.
DR   PDB; 4BW8; X-ray; 1.80 A; A/B=1-149.
DR   PDB; 4BYF; X-ray; 2.74 A; B/D=1-149.
DR   PDB; 4DCK; X-ray; 2.20 A; B=1-149.
DR   PDB; 4DJC; X-ray; 1.35 A; A=1-149.
DR   PDB; 4GOW; X-ray; 2.60 A; D=4-147.
DR   PDB; 4JPZ; X-ray; 3.02 A; C/I=1-149.
DR   PDB; 4JQ0; X-ray; 3.84 A; C=1-149.
DR   PDB; 4L79; X-ray; 2.30 A; B=1-149.
DR   PDB; 4LZX; X-ray; 1.50 A; A=2-149.
DR   PDB; 4M1L; X-ray; 2.10 A; A=2-149.
DR   PDB; 4OVN; X-ray; 2.80 A; A/B/C/D/E=1-149.
DR   PDB; 4Q57; X-ray; 1.80 A; A=10-74.
DR   PDB; 4Q5U; X-ray; 1.95 A; A=1-149.
DR   PDB; 4UMO; X-ray; 3.00 A; C/D=1-149.
DR   PDB; 4UPU; X-ray; 2.34 A; A=2-149.
DR   PDB; 4V0C; X-ray; 2.86 A; C/D=1-149.
DR   PDB; 5COC; X-ray; 2.67 A; A=5-78.
DR   PDB; 5DBR; X-ray; 2.25 A; A=5-149.
DR   PDB; 5DOW; X-ray; 1.70 A; A/C/E/G=2-149.
DR   PDB; 5DSU; X-ray; 1.93 A; A=3-78.
DR   PDB; 5GGM; NMR; -; A=2-149.
DR   PDB; 5I0I; X-ray; 3.15 A; C/E=3-147, G=84-126, I=84-147.
DR   PDB; 5J03; X-ray; 2.00 A; B=1-149.
DR   PDB; 5J8H; NMR; -; A=2-149.
DR   PDB; 5JQA; X-ray; 1.80 A; A=1-149.
DR   PDB; 5JTH; X-ray; 1.84 A; A=1-149.
DR   PDB; 5K7L; EM; 3.78 A; B=1-149.
DR   PDB; 5K8Q; X-ray; 1.74 A; A=1-149.
DR   PDB; 5OEO; NMR; -; A=1-149.
DR   PDB; 5TP5; NMR; -; A=2-149.
DR   PDB; 5TP6; NMR; -; A=2-149.
DR   PDB; 5V02; X-ray; 1.78 A; R=1-149.
DR   PDB; 5V03; X-ray; 1.58 A; R=1-149.
DR   PDB; 5V7X; X-ray; 3.14 A; B=1-149.
DR   PDB; 5WBX; X-ray; 1.90 A; R=5-148.
DR   PDB; 5WC5; X-ray; 2.30 A; R=5-148.
DR   PDB; 6B8L; X-ray; 2.30 A; B/D/F/H=1-149.
DR   PDB; 6B8M; X-ray; 2.30 A; B/D/F/H=1-149.
DR   PDB; 6B8N; X-ray; 2.20 A; B/D/F/H=1-149.
DR   PDB; 6B8P; X-ray; 2.20 A; B/D/F/H=1-149.
DR   PDB; 6B8Q; X-ray; 2.60 A; B/D/F/H=1-149.
DR   PDB; 6BUT; NMR; -; A=2-149.
DR   PDB; 6C1D; EM; 3.20 A; R=2-149.
DR   PDB; 6C1G; EM; 3.80 A; R=2-149.
DR   PDB; 6C1H; EM; 3.90 A; R=2-149.
DR   PDB; 6CNM; EM; 3.40 A; E/F/G/H=1-149.
DR   PDB; 6CNN; EM; 3.50 A; E/F/G/H=1-149.
DR   PDB; 6CNO; EM; 4.70 A; E/F/G/H=1-149.
DR   PDB; 6DAD; X-ray; 1.65 A; A/B=2-149.
DR   PDB; 6DAE; X-ray; 2.00 A; A/B=2-149.
DR   PDB; 6DAF; X-ray; 2.40 A; A/B=2-149.
DR   PDB; 6DAH; X-ray; 2.50 A; A/B/C/D=1-149.
DR   PDB; 6E2F; EM; 3.90 A; E=1-149.
DR   PDB; 6E2G; EM; 3.60 A; E=1-149.
DR   PDB; 6EEB; X-ray; 1.96 A; A=1-149.
DR   PDB; 6FEG; NMR; -; B=1-149.
DR   PDB; 6FEH; NMR; -; B=1-149.
DR   PDB; 6GDK; NMR; -; A=2-149.
DR   PDB; 6GDL; NMR; -; A=2-80.
DR   PDB; 6HCS; X-ray; 2.00 A; A/C/E/G=1-149.
DR   PDB; 6HR1; X-ray; 1.90 A; A/B=2-149.
DR   PDB; 6JI8; EM; 3.60 A; C/F/I/L=1-149.
DR   PDB; 6JII; EM; 4.20 A; C/F/I/L=1-149.
DR   PDB; 6JIU; EM; 4.20 A; C/F/I/L=1-149.
DR   PDB; 6JIY; EM; 3.90 A; C/F/I/L=1-149.
DR   PDB; 6JRS; EM; 3.70 A; C/F/I/L=1-149.
DR   PDB; 6JV2; EM; 4.40 A; B/D/F/H=1-149.
DR   PDB; 6K4K; X-ray; 2.71 A; C/D=1-149.
DR   PDB; 6K4L; X-ray; 2.95 A; C/D=1-149.
DR   PDB; 6K4R; X-ray; 3.11 A; C/D=1-149.
DR   PDB; 6M2W; EM; 3.80 A; C/F/I/L=1-149.
DR   PDB; 6M7H; X-ray; 1.60 A; A=2-148.
DR   PDB; 6MUD; X-ray; 2.69 A; A=1-149.
DR   PDB; 6MUE; X-ray; 1.90 A; A=1-149.
DR   PDB; 6N5W; X-ray; 2.15 A; C=1-149.
DR   PDB; 6O5G; X-ray; 1.89 A; A=1-149.
DR   PDB; 6OS4; X-ray; 2.05 A; A=2-149.
DR   PDB; 6PAW; X-ray; 2.95 A; C/D/G/H=1-149.
DR   PDB; 6PBX; EM; 4.00 A; B/D/F/H=1-149.
DR   PDB; 6PBY; EM; 3.67 A; B/D/F/H=1-149.
DR   PDB; 6TV7; X-ray; 2.90 A; A=3-149.
DR   PDB; 6U39; X-ray; 2.40 A; A/C/E/G/I/K/M/O/Q/S=2-149.
DR   PDB; 6U3A; X-ray; 1.65 A; A/B=2-149.
DR   PDB; 6U3B; X-ray; 1.70 A; A=2-149.
DR   PDB; 6U3D; X-ray; 1.75 A; A/B=2-149.
DR   PDB; 6UZZ; EM; 3.10 A; B/D/F/H=1-149.
DR   PDB; 6V00; EM; 3.10 A; B/E/H/K=1-149.
DR   PDB; 6V01; EM; 3.90 A; B/E/H/K=1-149.
DR   PDB; 6X32; EM; 3.80 A; C/F/I/L=3-148.
DR   PDB; 6X33; EM; 4.20 A; C/F/I/L=1-148.
DR   PDB; 6X35; EM; 4.20 A; C/F/I/L=1-148.
DR   PDB; 6X36; EM; 4.70 A; C/F/I/L=1-148.
DR   PDB; 6XXX; X-ray; 1.25 A; AAA=1-149.
DR   PDB; 6XY3; X-ray; 2.00 A; AAA=1-149.
DR   PDB; 6XYR; X-ray; 2.08 A; A=2-149.
DR   PDB; 6Y4P; X-ray; 2.13 A; A=1-149.
DR   PDB; 6Y94; NMR; -; A=2-149.
DR   PDB; 6Y95; NMR; -; A=2-149.
DR   PDB; 6YA9; X-ray; 2.15 A; A=3-149.
DR   PDB; 6YNS; X-ray; 3.94 A; A/B/C/D/E/F/G/H/I/J/K/L=2-149.
DR   PDB; 6YNU; X-ray; 3.12 A; A/C=2-149.
DR   PDB; 6ZBI; NMR; -; A=2-149.
DR   PDB; 7AUG; X-ray; 2.04 A; A=3-149.
DR   PDB; 7BF1; X-ray; 1.24 A; AAA=1-149.
DR   PDB; 7BF2; X-ray; 1.43 A; AAA=1-149.
DR   PDB; 7KL5; X-ray; 1.65 A; A=1-149.
DR   PDB; 7L8V; NMR; -; A=1-149.
DR   PDB; 7PSZ; X-ray; 1.90 A; A=2-149.
DR   PDB; 7PU9; X-ray; 2.28 A; A=2-149.
DR   PDB; 7SHQ; X-ray; 2.34 A; B=2-149.
DR   PDB; 7SX3; EM; 3.10 A; C=1-149.
DR   PDB; 7SX4; EM; 3.50 A; C=1-149.
DR   PDB; 7T2Q; X-ray; 1.95 A; A=2-149.
DR   PDB; 7TCI; EM; 3.90 A; B/D/F/H=1-149.
DR   PDB; 7TCP; EM; 3.84 A; B/D/F/H=1-149.
DR   PDB; 7TZC; EM; 2.45 A; C/D/E/K=1-149.
DR   PDB; 7U9T; EM; 2.68 A; I/J/K/L=1-149.
DR   PDB; 7UA3; EM; 2.97 A; I/J/K/L=1-149.
DR   PDB; 7UA4; EM; 2.93 A; I/J/K/L=1-149.
DR   PDB; 7VMB; X-ray; 2.00 A; C=1-149.
DR   PDB; 7VUO; X-ray; 2.68 A; C=2-149.
DR   PDB; 7VUR; X-ray; 1.70 A; A/B=77-149.
DR   PDB; 7VUS; X-ray; 1.70 A; A/B/C/D=77-149.
DR   PDB; 7VUT; X-ray; 1.70 A; A/B=77-149.
DR   PDB; 7VUU; X-ray; 1.95 A; A/B/C/D=77-149.
DR   PDB; 7VVD; X-ray; 3.13 A; C/E=1-149.
DR   PDB; 7VVH; X-ray; 2.30 A; C=1-149.
DR   PDB; 7WJI; EM; 4.50 A; E=1-149.
DR   PDB; 7WR3; X-ray; 1.87 A; C/D=1-149.
DR   PDB; 7WR4; X-ray; 2.75 A; B=1-149.
DR   PDB; 7WR5; X-ray; 3.10 A; B=1-149.
DR   PDB; 7WZS; X-ray; 3.60 A; C=1-149.
DR   PDB; 7XN4; EM; 3.35 A; D=1-149.
DR   PDB; 7XN5; EM; 3.18 A; D=1-149.
DR   PDB; 7XN6; EM; 3.45 A; D=1-149.
DR   PDB; 7ZRP; X-ray; 2.65 A; A/C=2-149.
DR   PDB; 7ZRQ; X-ray; 1.68 A; A=2-149.
DR   PDB; 8AHS; X-ray; 2.48 A; A=1-149.
DR   PDB; 8B6Q; X-ray; 2.60 A; A=3-148.
DR   PDB; 8BFG; NMR; -; A=2-149.
DR   PDB; 8DGH; NMR; -; A=1-149.
DR   PDB; 8DGK; NMR; -; A=1-149.
DR   PDB; 8DUJ; EM; 3.70 A; C/F/I/L=1-149.
DR   PDB; 8DVE; EM; 3.84 A; C/F/I/L=1-149.
DR   PDB; 8EOW; EM; 3.90 A; E/F/G/H=7-148.
DR   PDB; 8EP0; EM; 4.90 A; E/F/G/H=7-148.
DR   PDB; 8EP1; EM; 5.40 A; E/F/G/H=7-148.
DR   PDB; 8FNY; X-ray; 2.22 A; B/D=2-149.
DR   PDB; 8FO6; X-ray; 2.55 A; B=2-149.
DR   PDB; 8GM4; X-ray; 2.12 A; B=2-149.
DR   PDB; 8GM5; X-ray; 2.12 A; B=2-149.
DR   PDB; 8IJK; EM; 3.40 A; E/F/G/H=1-149.
DR   PDB; 8J00; EM; 3.00 A; E/F/G/H=1-149.
DR   PDB; 8J01; EM; 3.10 A; C/E/F/H=1-149.
DR   PDB; 8J02; EM; 3.50 A; C/E/F/H=1-149.
DR   PDB; 8J03; EM; 2.70 A; E/F/H/J=1-149.
DR   PDB; 8J04; EM; 2.70 A; C/E/F/H=1-149.
DR   PDB; 8J05; EM; 2.70 A; C/E/F/H=1-149.
DR   PDB; 8J07; EM; 4.10 A; W=1-149.
DR   PDB; 8JFK; EM; 2.90 A; D/H/L/P=1-149.
DR   PDB; 8ODZ; EM; 3.60 A; D=5-149.
DR   PDB; 8OE0; EM; 4.60 A; D=5-149.
DR   PDB; 8OE4; EM; 3.60 A; C=5-149.
DR   PDB; 8PB1; EM; 3.50 A; D=5-149.
DR   PDB; 8SIK; EM; 2.90 A; B/D/F/H=1-149.
DR   PDB; 8SIM; EM; 6.20 A; B/D/F/H=1-149.
DR   PDB; 8SIN; EM; 6.80 A; B/D/F/H=1-149.
DR   PDB; 8UXL; EM; 3.12 A; I/J/K/L=1-149.
DR   PDB; 8UXM; EM; 3.56 A; I/J/K/L=1-149.
DR   PDB; 8W4U; EM; 3.30 A; C/E/F/H=1-149.
DR   PDB; 8X43; EM; 3.00 A; B/D/F/H=1-149.
DR   PDB; 8XJI; EM; 3.91 A; I/J/K/L=1-148.
DR   PDB; 8XKH; EM; 3.87 A; I/J/K/L=1-149.
DR   PDB; 8XLF; EM; 3.62 A; I/J/K/L=1-148.
DR   PDB; 8XLH; EM; 3.62 A; I/J/K/L=1-149.
DR   PDB; 8XO1; EM; 3.80 A; C/E/G/H=1-149.
DR   PDB; 8XYA; EM; 2.70 A; D=1-149.
DR   PDB; 8XYB; EM; 3.10 A; D=1-149.
DR   PDB; 8Y40; EM; 3.58 A; I/J/K/L=1-149.
DR   PDB; 9CUI; EM; 3.42 A; E=1-149.
DR   PDB; 9CUK; EM; 3.26 A; E=1-149.
DR   PDB; 9E17; EM; 2.45 A; C/D/E/K=1-149.
DR   PDB; 9JQI; X-ray; 2.10 A; A/B/C=1-149.
DR   PDB; 9K8W; X-ray; 2.65 A; A=1-149.
DR   PDB; 9K8X; X-ray; 2.05 A; A=1-149.
DR   PDBsum; 1CDL; -.
DR   PDBsum; 1CLL; -.
DR   PDBsum; 1CTR; -.
DR   PDBsum; 1IWQ; -.
DR   PDBsum; 1J7O; -.
DR   PDBsum; 1J7P; -.
DR   PDBsum; 1K90; -.
DR   PDBsum; 1K93; -.
DR   PDBsum; 1L7Z; -.
DR   PDBsum; 1LVC; -.
DR   PDBsum; 1NKF; -.
DR   PDBsum; 1PK0; -.
DR   PDBsum; 1S26; -.
DR   PDBsum; 1SK6; -.
DR   PDBsum; 1SW8; -.
DR   PDBsum; 1UP5; -.
DR   PDBsum; 1WRZ; -.
DR   PDBsum; 1XFU; -.
DR   PDBsum; 1XFV; -.
DR   PDBsum; 1XFW; -.
DR   PDBsum; 1XFX; -.
DR   PDBsum; 1XFY; -.
DR   PDBsum; 1XFZ; -.
DR   PDBsum; 1Y6W; -.
DR   PDBsum; 1YR5; -.
DR   PDBsum; 1YRT; -.
DR   PDBsum; 1YRU; -.
DR   PDBsum; 1ZOT; -.
DR   PDBsum; 1ZUZ; -.
DR   PDBsum; 2BE6; -.
DR   PDBsum; 2F3Y; -.
DR   PDBsum; 2F3Z; -.
DR   PDBsum; 2HF5; -.
DR   PDBsum; 2I08; -.
DR   PDBsum; 2JZI; -.
DR   PDBsum; 2K0E; -.
DR   PDBsum; 2K0F; -.
DR   PDBsum; 2K0J; -.
DR   PDBsum; 2K61; -.
DR   PDBsum; 2KNE; -.
DR   PDBsum; 2KUG; -.
DR   PDBsum; 2KUH; -.
DR   PDBsum; 2L53; -.
DR   PDBsum; 2L7L; -.
DR   PDBsum; 2LGF; -.
DR   PDBsum; 2LL6; -.
DR   PDBsum; 2LL7; -.
DR   PDBsum; 2LQC; -.
DR   PDBsum; 2LQP; -.
DR   PDBsum; 2LV6; -.
DR   PDBsum; 2M0J; -.
DR   PDBsum; 2M0K; -.
DR   PDBsum; 2M55; -.
DR   PDBsum; 2MG5; -.
DR   PDBsum; 2N27; -.
DR   PDBsum; 2N6A; -.
DR   PDBsum; 2N77; -.
DR   PDBsum; 2N8J; -.
DR   PDBsum; 2R28; -.
DR   PDBsum; 2V01; -.
DR   PDBsum; 2V02; -.
DR   PDBsum; 2VAY; -.
DR   PDBsum; 2W73; -.
DR   PDBsum; 2WEL; -.
DR   PDBsum; 2X0G; -.
DR   PDBsum; 2Y4V; -.
DR   PDBsum; 3BYA; -.
DR   PDBsum; 3DVE; -.
DR   PDBsum; 3DVJ; -.
DR   PDBsum; 3DVK; -.
DR   PDBsum; 3DVM; -.
DR   PDBsum; 3EVV; -.
DR   PDBsum; 3EWT; -.
DR   PDBsum; 3EWV; -.
DR   PDBsum; 3G43; -.
DR   PDBsum; 3HR4; -.
DR   PDBsum; 3J41; -.
DR   PDBsum; 3O77; -.
DR   PDBsum; 3O78; -.
DR   PDBsum; 3OXQ; -.
DR   PDBsum; 3SUI; -.
DR   PDBsum; 3UCT; -.
DR   PDBsum; 3UCW; -.
DR   PDBsum; 3UCY; -.
DR   PDBsum; 4BW7; -.
DR   PDBsum; 4BW8; -.
DR   PDBsum; 4BYF; -.
DR   PDBsum; 4DCK; -.
DR   PDBsum; 4DJC; -.
DR   PDBsum; 4GOW; -.
DR   PDBsum; 4JPZ; -.
DR   PDBsum; 4JQ0; -.
DR   PDBsum; 4L79; -.
DR   PDBsum; 4LZX; -.
DR   PDBsum; 4M1L; -.
DR   PDBsum; 4OVN; -.
DR   PDBsum; 4Q57; -.
DR   PDBsum; 4Q5U; -.
DR   PDBsum; 4UMO; -.
DR   PDBsum; 4UPU; -.
DR   PDBsum; 4V0C; -.
DR   PDBsum; 5COC; -.
DR   PDBsum; 5DBR; -.
DR   PDBsum; 5DOW; -.
DR   PDBsum; 5DSU; -.
DR   PDBsum; 5GGM; -.
DR   PDBsum; 5I0I; -.
DR   PDBsum; 5J03; -.
DR   PDBsum; 5J8H; -.
DR   PDBsum; 5JQA; -.
DR   PDBsum; 5JTH; -.
DR   PDBsum; 5K7L; -.
DR   PDBsum; 5K8Q; -.
DR   PDBsum; 5OEO; -.
DR   PDBsum; 5TP5; -.
DR   PDBsum; 5TP6; -.
DR   PDBsum; 5V02; -.
DR   PDBsum; 5V03; -.
DR   PDBsum; 5V7X; -.
DR   PDBsum; 5WBX; -.
DR   PDBsum; 5WC5; -.
DR   PDBsum; 6B8L; -.
DR   PDBsum; 6B8M; -.
DR   PDBsum; 6B8N; -.
DR   PDBsum; 6B8P; -.
DR   PDBsum; 6B8Q; -.
DR   PDBsum; 6BUT; -.
DR   PDBsum; 6C1D; -.
DR   PDBsum; 6C1G; -.
DR   PDBsum; 6C1H; -.
DR   PDBsum; 6CNM; -.
DR   PDBsum; 6CNN; -.
DR   PDBsum; 6CNO; -.
DR   PDBsum; 6DAD; -.
DR   PDBsum; 6DAE; -.
DR   PDBsum; 6DAF; -.
DR   PDBsum; 6DAH; -.
DR   PDBsum; 6E2F; -.
DR   PDBsum; 6E2G; -.
DR   PDBsum; 6EEB; -.
DR   PDBsum; 6FEG; -.
DR   PDBsum; 6FEH; -.
DR   PDBsum; 6GDK; -.
DR   PDBsum; 6GDL; -.
DR   PDBsum; 6HCS; -.
DR   PDBsum; 6HR1; -.
DR   PDBsum; 6JI8; -.
DR   PDBsum; 6JII; -.
DR   PDBsum; 6JIU; -.
DR   PDBsum; 6JIY; -.
DR   PDBsum; 6JRS; -.
DR   PDBsum; 6JV2; -.
DR   PDBsum; 6K4K; -.
DR   PDBsum; 6K4L; -.
DR   PDBsum; 6K4R; -.
DR   PDBsum; 6M2W; -.
DR   PDBsum; 6M7H; -.
DR   PDBsum; 6MUD; -.
DR   PDBsum; 6MUE; -.
DR   PDBsum; 6N5W; -.
DR   PDBsum; 6O5G; -.
DR   PDBsum; 6OS4; -.
DR   PDBsum; 6PAW; -.
DR   PDBsum; 6PBX; -.
DR   PDBsum; 6PBY; -.
DR   PDBsum; 6TV7; -.
DR   PDBsum; 6U39; -.
DR   PDBsum; 6U3A; -.
DR   PDBsum; 6U3B; -.
DR   PDBsum; 6U3D; -.
DR   PDBsum; 6UZZ; -.
DR   PDBsum; 6V00; -.
DR   PDBsum; 6V01; -.
DR   PDBsum; 6X32; -.
DR   PDBsum; 6X33; -.
DR   PDBsum; 6X35; -.
DR   PDBsum; 6X36; -.
DR   PDBsum; 6XXX; -.
DR   PDBsum; 6XY3; -.
DR   PDBsum; 6XYR; -.
DR   PDBsum; 6Y4P; -.
DR   PDBsum; 6Y94; -.
DR   PDBsum; 6Y95; -.
DR   PDBsum; 6YA9; -.
DR   PDBsum; 6YNS; -.
DR   PDBsum; 6YNU; -.
DR   PDBsum; 6ZBI; -.
DR   PDBsum; 7AUG; -.
DR   PDBsum; 7BF1; -.
DR   PDBsum; 7BF2; -.
DR   PDBsum; 7KL5; -.
DR   PDBsum; 7L8V; -.
DR   PDBsum; 7PSZ; -.
DR   PDBsum; 7PU9; -.
DR   PDBsum; 7SHQ; -.
DR   PDBsum; 7SX3; -.
DR   PDBsum; 7SX4; -.
DR   PDBsum; 7T2Q; -.
DR   PDBsum; 7TCI; -.
DR   PDBsum; 7TCP; -.
DR   PDBsum; 7TZC; -.
DR   PDBsum; 7U9T; -.
DR   PDBsum; 7UA3; -.
DR   PDBsum; 7UA4; -.
DR   PDBsum; 7VMB; -.
DR   PDBsum; 7VUO; -.
DR   PDBsum; 7VUR; -.
DR   PDBsum; 7VUS; -.
DR   PDBsum; 7VUT; -.
DR   PDBsum; 7VUU; -.
DR   PDBsum; 7VVD; -.
DR   PDBsum; 7VVH; -.
DR   PDBsum; 7WJI; -.
DR   PDBsum; 7WR3; -.
DR   PDBsum; 7WR4; -.
DR   PDBsum; 7WR5; -.
DR   PDBsum; 7WZS; -.
DR   PDBsum; 7XN4; -.
DR   PDBsum; 7XN5; -.
DR   PDBsum; 7XN6; -.
DR   PDBsum; 7ZRP; -.
DR   PDBsum; 7ZRQ; -.
DR   PDBsum; 8AHS; -.
DR   PDBsum; 8B6Q; -.
DR   PDBsum; 8BFG; -.
DR   PDBsum; 8DGH; -.
DR   PDBsum; 8DGK; -.
DR   PDBsum; 8DUJ; -.
DR   PDBsum; 8DVE; -.
DR   PDBsum; 8EOW; -.
DR   PDBsum; 8EP0; -.
DR   PDBsum; 8EP1; -.
DR   PDBsum; 8FNY; -.
DR   PDBsum; 8FO6; -.
DR   PDBsum; 8GM4; -.
DR   PDBsum; 8GM5; -.
DR   PDBsum; 8IJK; -.
DR   PDBsum; 8J00; -.
DR   PDBsum; 8J01; -.
DR   PDBsum; 8J02; -.
DR   PDBsum; 8J03; -.
DR   PDBsum; 8J04; -.
DR   PDBsum; 8J05; -.
DR   PDBsum; 8J07; -.
DR   PDBsum; 8JFK; -.
DR   PDBsum; 8ODZ; -.
DR   PDBsum; 8OE0; -.
DR   PDBsum; 8OE4; -.
DR   PDBsum; 8PB1; -.
DR   PDBsum; 8SIK; -.
DR   PDBsum; 8SIM; -.
DR   PDBsum; 8SIN; -.
DR   PDBsum; 8UXL; -.
DR   PDBsum; 8UXM; -.
DR   PDBsum; 8W4U; -.
DR   PDBsum; 8X43; -.
DR   PDBsum; 8XJI; -.
DR   PDBsum; 8XKH; -.
DR   PDBsum; 8XLF; -.
DR   PDBsum; 8XLH; -.
DR   PDBsum; 8XO1; -.
DR   PDBsum; 8XYA; -.
DR   PDBsum; 8XYB; -.
DR   PDBsum; 8Y40; -.
DR   PDBsum; 9CUI; -.
DR   PDBsum; 9CUK; -.
DR   PDBsum; 9E17; -.
DR   PDBsum; 9JQI; -.
DR   PDBsum; 9K8W; -.
DR   PDBsum; 9K8X; -.
DR   AlphaFoldDB; P0DP23; -.
DR   EMDB; EMD-16820; -.
DR   EMDB; EMD-16821; -.
DR   EMDB; EMD-16824; -.
DR   EMDB; EMD-17580; -.
DR   EMDB; EMD-20294; -.
DR   EMDB; EMD-20295; -.
DR   EMDB; EMD-20965; -.
DR   EMDB; EMD-20966; -.
DR   EMDB; EMD-20967; -.
DR   EMDB; EMD-22015; -.
DR   EMDB; EMD-22016; -.
DR   EMDB; EMD-22018; -.
DR   EMDB; EMD-22019; -.
DR   EMDB; EMD-25492; -.
DR   EMDB; EMD-25493; -.
DR   EMDB; EMD-25813; -.
DR   EMDB; EMD-25816; -.
DR   EMDB; EMD-26205; -.
DR   EMDB; EMD-26408; -.
DR   EMDB; EMD-26413; -.
DR   EMDB; EMD-26414; -.
DR   EMDB; EMD-27721; -.
DR   EMDB; EMD-27736; -.
DR   EMDB; EMD-28487; -.
DR   EMDB; EMD-28494; -.
DR   EMDB; EMD-28498; -.
DR   EMDB; EMD-30067; -.
DR   EMDB; EMD-32544; -.
DR   EMDB; EMD-33310; -.
DR   EMDB; EMD-33311; -.
DR   EMDB; EMD-33312; -.
DR   EMDB; EMD-35487; -.
DR   EMDB; EMD-35879; -.
DR   EMDB; EMD-35880; -.
DR   EMDB; EMD-35881; -.
DR   EMDB; EMD-35882; -.
DR   EMDB; EMD-35883; -.
DR   EMDB; EMD-35884; -.
DR   EMDB; EMD-35888; -.
DR   EMDB; EMD-36212; -.
DR   EMDB; EMD-37270; -.
DR   EMDB; EMD-38041; -.
DR   EMDB; EMD-38398; -.
DR   EMDB; EMD-38417; -.
DR   EMDB; EMD-38447; -.
DR   EMDB; EMD-38448; -.
DR   EMDB; EMD-38522; -.
DR   EMDB; EMD-38908; -.
DR   EMDB; EMD-40508; -.
DR   EMDB; EMD-40509; -.
DR   EMDB; EMD-40510; -.
DR   EMDB; EMD-42768; -.
DR   EMDB; EMD-42769; -.
DR   EMDB; EMD-45934; -.
DR   EMDB; EMD-45936; -.
DR   EMDB; EMD-7329; -.
DR   EMDB; EMD-7330; -.
DR   EMDB; EMD-7331; -.
DR   EMDB; EMD-7537; -.
DR   EMDB; EMD-7538; -.
DR   EMDB; EMD-7539; -.
DR   EMDB; EMD-8961; -.
DR   EMDB; EMD-8962; -.
DR   EMDB; EMD-9833; -.
DR   EMDB; EMD-9834; -.
DR   EMDB; EMD-9836; -.
DR   EMDB; EMD-9837; -.
DR   EMDB; EMD-9880; -.
DR   EMDB; EMD-9889; -.
DR   SASBDB; P0DP23; -.
DR   SMR; P0DP23; -.
DR   ComplexPortal; CPX-1001; Calcineurin-Calmodulin complex, gamma-R1 variant.
DR   ComplexPortal; CPX-1002; Calcineurin-Calmodulin complex, beta-R2 variant.
DR   ComplexPortal; CPX-1003; Calcineurin-Calmodulin complex, alpha-R1 variant.
DR   ComplexPortal; CPX-1009; Calcineurin-Calmodulin complex, beta-R1 variant.
DR   ComplexPortal; CPX-102; DAPK1 - calmodulin complex.
DR   ComplexPortal; CPX-1048; Calcineurin-Calmodulin complex, alpha-R2 variant.
DR   ComplexPortal; CPX-1050; Calcineurin-Calmodulin complex, gamma-R2 variant.
DR   ComplexPortal; CPX-1112; Calcineurin-Calmodulin-AKAP5 complex, gamma-R1 variant.
DR   ComplexPortal; CPX-1114; Calcineurin-Calmodulin-AKAP5 complex, alpha-R2 variant.
DR   ComplexPortal; CPX-1116; Calcineurin-Calmodulin-AKAP5 complex, beta-R2 variant.
DR   ComplexPortal; CPX-1118; Calcineurin-Calmodulin-AKAP5 complex, gamma-R2 variant.
DR   ComplexPortal; CPX-2341; NALCN channelosome complex.
DR   ComplexPortal; CPX-2640; Phosphorylase kinase, muscle variant.
DR   ComplexPortal; CPX-674; Calcineurin-Calmodulin-AKAP5 complex, alpha-R1 variant.
DR   ComplexPortal; CPX-902; Kv7.1 channel complex.
DR   ComplexPortal; CPX-9141; Silencing factor of the integrated stress response complex.
DR   ComplexPortal; CPX-9581; Phosphorylase kinase, liver variant.
DR   ComplexPortal; CPX-998; Calcineurin-Calmodulin-AKAP5 complex, beta-R1 variant.
DR   CORUM; P0DP23; -.
DR   FunCoup; P0DP23; 3752.
DR   IntAct; P0DP23; 89.
DR   MINT; P0DP23; -.
DR   STRING; 9606.ENSP00000291295; -.
DR   BindingDB; P0DP23; -.
DR   ChEMBL; CHEMBL6093; -.
DR   DrugBank; DB08039; (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE.
DR   DrugBank; DB14511; Acetate.
DR   DrugBank; DB01429; Aprindine.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB01373; Calcium.
DR   DrugBank; DB11093; Calcium citrate.
DR   DrugBank; DB13800; Calcium levulinate.
DR   DrugBank; DB11348; Calcium Phosphate.
DR   DrugBank; DB14481; Calcium phosphate dihydrate.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB00527; Cinchocaine.
DR   DrugBank; DB02868; Deacetoxyvinzolidine.
DR   DrugBank; DB04209; Dequalinium.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB04841; Flunarizine.
DR   DrugBank; DB00623; Fluphenazine.
DR   DrugBank; DB01218; Halofantrine.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00836; Loperamide.
DR   DrugBank; DB01065; Melatonin.
DR   DrugBank; DB08231; Myristic acid.
DR   DrugBank; DB04513; N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB00850; Perphenazine.
DR   DrugBank; DB00925; Phenoxybenzamine.
DR   DrugBank; DB01100; Pimozide.
DR   DrugBank; DB04825; Prenylamine.
DR   DrugBank; DB01069; Promethazine.
DR   DrugBank; DB03900; tert-butanol.
DR   DrugBank; DB00831; Trifluoperazine.
DR   DrugBank; DB03977; Trimethyllysine.
DR   DrugCentral; P0DP23; -.
DR   MoonDB; P0DP23; Predicted.
DR   GlyGen; P0DP23; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P0DP23; -.
DR   MetOSite; P0DP23; -.
DR   PhosphoSitePlus; P0DP23; -.
DR   BioMuta; CALM1; -.
DR   jPOST; P0DP23; -.
DR   MassIVE; P0DP23; -.
DR   PaxDb; 9606-ENSP00000272298; -.
DR   PeptideAtlas; P0DP23; -.
DR   Pumba; P0DP23; -.
DR   Antibodypedia; 4344; 514 antibodies from 34 providers.
DR   DNASU; 801; -.
DR   Ensembl; ENST00000356978.9; ENSP00000349467.4; ENSG00000198668.14.
DR   GeneID; 801; -.
DR   GeneID; 805; -.
DR   GeneID; 808; -.
DR   KEGG; hsa:801; -.
DR   KEGG; hsa:805; -.
DR   KEGG; hsa:808; -.
DR   MANE-Select; ENST00000356978.9; ENSP00000349467.4; NM_006888.6; NP_008819.1.
DR   AGR; HGNC:1442; -.
DR   AGR; HGNC:1445; -.
DR   AGR; HGNC:1449; -.
DR   CTD; 801; -.
DR   CTD; 805; -.
DR   CTD; 808; -.
DR   DisGeNET; 801; -.
DR   DisGeNET; 805; -.
DR   DisGeNET; 808; -.
DR   GeneCards; CALM1; -.
DR   GeneReviews; CALM1; -.
DR   HGNC; HGNC:1442; CALM1.
DR   HPA; ENSG00000198668; Low tissue specificity.
DR   MalaCards; CALM1; -.
DR   MIM; 114180; gene.
DR   MIM; 614916; phenotype.
DR   MIM; 616247; phenotype.
DR   neXtProt; NX_P0DP23; -.
DR   OpenTargets; ENSG00000143933; -.
DR   OpenTargets; ENSG00000160014; -.
DR   OpenTargets; ENSG00000198668; -.
DR   Orphanet; 3286; Catecholaminergic polymorphic ventricular tachycardia.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   VEuPathDB; HostDB:ENSG00000198668; -.
DR   eggNOG; KOG0027; Eukaryota.
DR   InParanoid; P0DP23; -.
DR   OMA; ARKMKEC; -.
DR   OrthoDB; 9924840at2759; -.
DR   PAN-GO; P0DP23; 2 GO annotations based on evolutionary models.
DR   PathwayCommons; P0DP23; -.
DR   Reactome; R-HSA-111932; CaMK IV-mediated phosphorylation of CREB.
DR   Reactome; R-HSA-111933; Calmodulin induced events.
DR   Reactome; R-HSA-111957; Cam-PDE 1 activation.
DR   Reactome; R-HSA-111997; CaM pathway.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-HSA-163615; PKA activation.
DR   Reactome; R-HSA-180024; DARPP-32 events.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-HSA-2025928; Calcineurin activates NFAT.
DR   Reactome; R-HSA-203615; eNOS activation.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-418359; Reduction of cytosolic Ca++ levels.
DR   Reactome; R-HSA-425561; Sodium/Calcium exchangers.
DR   Reactome; R-HSA-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-HSA-442720; CREB1 phosphorylation through the activation of Adenylate Cyclase.
DR   Reactome; R-HSA-442729; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde.
DR   Reactome; R-HSA-442982; Ras activation upon Ca2+ influx through NMDA receptor.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   Reactome; R-HSA-451308; Activation of Ca-permeable Kainate Receptor.
DR   Reactome; R-HSA-5210891; Uptake and function of anthrax toxins.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-5218921; VEGFR2 mediated cell proliferation.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-5607763; CLEC7A (Dectin-1) induces NFAT activation.
DR   Reactome; R-HSA-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-HSA-5627123; RHO GTPases activate PAKs.
DR   Reactome; R-HSA-5673000; RAF activation.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF1 fusions.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   Reactome; R-HSA-8876725; Protein methylation.
DR   Reactome; R-HSA-9009391; Extra-nuclear estrogen signaling.
DR   Reactome; R-HSA-9022535; Loss of phosphorylation of MECP2 at T308.
DR   Reactome; R-HSA-9022692; Regulation of MECP2 expression and activity.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   Reactome; R-HSA-9617324; Negative regulation of NMDA receptor-mediated neuronal transmission.
DR   Reactome; R-HSA-9619229; Activation of RAC1 downstream of NMDARs.
DR   Reactome; R-HSA-9619483; Activation of AMPK downstream of NMDARs.
DR   Reactome; R-HSA-9620244; Long-term potentiation.
DR   Reactome; R-HSA-9648002; RAS processing.
DR   Reactome; R-HSA-9649948; Signaling downstream of RAS mutants.
DR   Reactome; R-HSA-9656223; Signaling by RAF1 mutants.
DR   Reactome; R-HSA-9664323; FCGR3A-mediated IL10 synthesis.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   Reactome; R-HSA-9856530; High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells.
DR   SignaLink; P0DP23; -.
DR   SIGNOR; P0DP23; -.
DR   BioGRID-ORCS; 801; 10 hits in 1158 CRISPR screens.
DR   BioGRID-ORCS; 805; 38 hits in 1009 CRISPR screens.
DR   BioGRID-ORCS; 808; 46 hits in 1159 CRISPR screens.
DR   ChiTaRS; CALM1; human.
DR   EvolutionaryTrace; P0DP23; -.
DR   Pharos; P0DP23; Tclin.
DR   PRO; PR:P0DP23; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; P0DP23; protein.
DR   Bgee; ENSG00000198668; Expressed in lateral nuclear group of thalamus and 211 other cell types or tissues.
DR   ExpressionAtlas; P0DP23; baseline and differential.
DR   GO; GO:0034704; C:calcium channel complex; IDA:BHF-UCL.
DR   GO; GO:0044305; C:calyx of Held; IEA:Ensembl.
DR   GO; GO:1902494; C:catalytic complex; IDA:CAFA.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0043209; C:myelin sheath; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:UniProtKB.
DR   GO; GO:0099523; C:presynaptic cytosol; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:CAFA.
DR   GO; GO:0030017; C:sarcomere; IDA:BHF-UCL.
DR   GO; GO:0097225; C:sperm midpiece; IEA:Ensembl.
DR   GO; GO:0005876; C:spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:Ensembl.
DR   GO; GO:0010856; F:adenylate cyclase activator activity; IDA:UniProtKB.
DR   GO; GO:0019855; F:calcium channel inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0005246; F:calcium channel regulator activity; IDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0072542; F:protein phosphatase activator activity; IDA:BHF-UCL.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator activity; IDA:UniProtKB.
DR   GO; GO:0031432; F:titin binding; IPI:BHF-UCL.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:BHF-UCL.
DR   GO; GO:0016240; P:autophagosome membrane docking; IDA:UniProtKB.
DR   GO; GO:0097720; P:calcineurin-mediated signaling; IDA:BHF-UCL.
DR   GO; GO:0035458; P:cellular response to interferon-beta; IDA:UniProt.
DR   GO; GO:0071346; P:cellular response to type II interferon; IDA:UniProt.
DR   GO; GO:0005513; P:detection of calcium ion; IMP:BHF-UCL.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0060291; P:long-term synaptic potentiation; TAS:BHF-UCL.
DR   GO; GO:1990456; P:mitochondrion-endoplasmic reticulum membrane tethering; IDA:UniProtKB.
DR   GO; GO:1905913; P:negative regulation of calcium ion export across plasma membrane; IEA:Ensembl.
DR   GO; GO:1901842; P:negative regulation of high voltage-gated calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:0140056; P:organelle localization by membrane tethering; IDA:UniProtKB.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; IDA:UniProt.
DR   GO; GO:0140238; P:presynaptic endocytosis; IEA:Ensembl.
DR   GO; GO:0050848; P:regulation of calcium-mediated signaling; IEA:Ensembl.
DR   GO; GO:0098901; P:regulation of cardiac muscle cell action potential; IMP:UniProtKB.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IDA:BHF-UCL.
DR   GO; GO:1901844; P:regulation of cell communication by electrical coupling involved in cardiac conduction; IC:BHF-UCL.
DR   GO; GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0002027; P:regulation of heart rate; IMP:BHF-UCL.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:0051592; P:response to calcium ion; IDA:BHF-UCL.
DR   GO; GO:0021762; P:substantia nigra development; HEP:UniProtKB.
DR   CDD; cd00051; EFh; 2.
DR   FunFam; 1.10.238.10:FF:000527; Calmodulin-3; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 3.
DR   IDEAL; IID00706; -.
DR   InterPro; IPR050230; CALM/Myosin/TropC-like.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   PANTHER; PTHR23048:SF0; CALMODULIN LIKE 3; 1.
DR   PANTHER; PTHR23048; MYOSIN LIGHT CHAIN 1, 3; 1.
DR   Pfam; PF13499; EF-hand_7; 2.
DR   PRINTS; PR00450; RECOVERIN.
DR   SMART; SM00054; EFh; 4.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   PROSITE; PS00018; EF_HAND_1; 4.
DR   PROSITE; PS50222; EF_HAND_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Cell projection; Cilium; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Disease variant; Flagellum;
KW   Host-virus interaction; Isopeptide bond; Long QT syndrome; Metal-binding;
KW   Methylation; Phosphoprotein; Reference proteome; Repeat; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:7093203, ECO:0000269|Ref.7,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   CHAIN           2..149
FT                   /note="Calmodulin-1"
FT                   /id="PRO_0000439932"
FT   DOMAIN          8..43
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          44..79
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          81..116
FT                   /note="EF-hand 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          117..149
FT                   /note="EF-hand 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          77..149
FT                   /note="Necessary and sufficient for interaction with PCP4"
FT                   /evidence="ECO:0000269|PubMed:27876793"
FT   BINDING         21
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         23
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         25
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         27
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         32
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         57
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         59
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         61
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         63
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         68
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:25441029,
FT                   ECO:0000269|PubMed:27564677, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:4UMO, ECO:0007744|PDB:4V0C,
FT                   ECO:0007744|PDB:5J03"
FT   BINDING         94
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0000269|PubMed:29724949, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:5J03, ECO:0007744|PDB:6CNN,
FT                   ECO:0007744|PDB:6CNO"
FT   BINDING         96
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0000269|PubMed:29724949, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:5J03, ECO:0007744|PDB:6CNN,
FT                   ECO:0007744|PDB:6CNO"
FT   BINDING         98
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0000269|PubMed:29724949, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:5J03, ECO:0007744|PDB:6CNN,
FT                   ECO:0007744|PDB:6CNO"
FT   BINDING         100
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0000269|PubMed:29724949, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:5J03, ECO:0007744|PDB:6CNN,
FT                   ECO:0007744|PDB:6CNO"
FT   BINDING         105
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0000269|PubMed:29724949, ECO:0007744|PDB:1CLL,
FT                   ECO:0007744|PDB:5J03, ECO:0007744|PDB:6CNN,
FT                   ECO:0007744|PDB:6CNO"
FT   BINDING         130
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03"
FT   BINDING         132
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03"
FT   BINDING         134
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03"
FT   BINDING         136
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03"
FT   BINDING         141
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677,
FT                   ECO:0007744|PDB:1CLL, ECO:0007744|PDB:5J03"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:7093203, ECO:0000269|Ref.7,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   MOD_RES         22
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         45
FT                   /note="Phosphothreonine; by CaMK4"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP29"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         95
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         100
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         102
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         111
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         116
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7093203,
FT                   ECO:0007744|PubMed:24129315"
FT   MOD_RES         116
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         139
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   CROSSLNK        22
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        22
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62157"
FT   VARIANT         54
FT                   /note="N -> I (in CPVT4; increased RYR2 calcium-release
FT                   channel activity; not changed calcium-dependent
FT                   inactivation of L-type calcium channel; not changed protein
FT                   abundance; not changed structure; not changed thermal
FT                   stability both in the absence and presence of calcium; no
FT                   effect on the calcium binding affinity; significantly
FT                   increased binding of RYR2; increased ryanodine-sensitive
FT                   calcium-release channel activity; decreased of KCNN2
FT                   calcium-activated potassium channel activity; not changed
FT                   KCNN2 expression; not changed KCNN2 location at membrane;
FT                   dbSNP:rs267607276)"
FT                   /evidence="ECO:0000269|PubMed:23040497,
FT                   ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696,
FT                   ECO:0000269|PubMed:27516456"
FT                   /id="VAR_069222"
FT   VARIANT         90
FT                   /note="F -> L (in LQT14; significantly decreased of KCNN2
FT                   calcium-activated potassium channel activity; not changed
FT                   KCNN2 expression; not changed KCNN2 location at membrane;
FT                   decreased thermal stability in presence of calcium ions;
FT                   decreased interaction with RYR2; dbSNP:rs730882253)"
FT                   /evidence="ECO:0000269|PubMed:24076290,
FT                   ECO:0000269|PubMed:25036739, ECO:0000269|PubMed:27165696"
FT                   /id="VAR_073275"
FT   VARIANT         98
FT                   /note="N -> S (in CPVT4; the mutant has significantly
FT                   reduced calcium affinity compared to wild-type;
FT                   calmodulin-RYR2 interaction is defective at low
FT                   intracellular Ca(2+) concentrations and restored at
FT                   moderate to high Ca(2+) concentrations; increased RYR2
FT                   calcium-release channel activity; decreased KCNN2
FT                   calcium-activated potassium channel activity; not changed
FT                   KCNN2 expression; not changed KCNN2 location at membrane;
FT                   dbSNP:rs267607277)"
FT                   /evidence="ECO:0000269|PubMed:23040497,
FT                   ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696,
FT                   ECO:0000269|PubMed:27516456"
FT                   /id="VAR_078541"
FT   VARIANT         130
FT                   /note="D -> G (in LQT14; reduction in calcium affinity; not
FT                   changed protein abundance; not changed structure;
FT                   significantly decreased thermal stability in presence of
FT                   calcium; significantly decreased RYR2 interaction;
FT                   increased ryanodine-sensitive calcium-release channel
FT                   activity; decreased of KCNN2 calcium-activated potassium
FT                   channel activity; not changed KCNN2 expression; not changed
FT                   KCNN2 location at membrane; dbSNP:rs730882252)"
FT                   /evidence="ECO:0000269|PubMed:23388215,
FT                   ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696"
FT                   /id="VAR_078542"
FT   VARIANT         141
FT                   /note="E -> G (in LQT14; decreased calcium affinity; loss
FT                   of CACNA1C calcium-dependent-inactivation; no effect on
FT                   intracellular RYR2-mediated calcium release;
FT                   dbSNP:rs1887120112)"
FT                   /evidence="ECO:0000269|PubMed:26969752"
FT                   /id="VAR_078263"
FT   VARIANT         141
FT                   /note="E -> V (in LQT14; loss-of-function variant causing
FT                   impaired negative regulation of high voltage-gated calcium
FT                   channel activity; impaired regulation of cardiac muscle
FT                   cell action potential; decreased calcium ion binding;
FT                   dbSNP:rs1887120112)"
FT                   /evidence="ECO:0000269|PubMed:31454269"
FT                   /id="VAR_083814"
FT   VARIANT         142
FT                   /note="F -> L (in LQT14; reduction in calcium affinity; not
FT                   changed protein abundance; not changed structure;
FT                   significantly decreased thermal stability in presence of
FT                   calcium; no effect on RYR2 interaction; significantly
FT                   reduced ryanodine-sensitive calcium-release channel
FT                   activity; impaired negative regulation of high
FT                   voltage-gated calcium channel activity; impaired regulation
FT                   of cardiac muscle cell action potential; dbSNP:rs1085307479
FT                   and dbSNP:rs199744595)"
FT                   /evidence="ECO:0000269|PubMed:23388215,
FT                   ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752,
FT                   ECO:0000269|PubMed:28158429"
FT                   /id="VAR_073282"
FT   HELIX           2..4
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   HELIX           7..20
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   STRAND          21..23
FT                   /evidence="ECO:0007829|PDB:2M0J"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   HELIX           30..39
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   HELIX           46..56
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   HELIX           57..59
FT                   /evidence="ECO:0007829|PDB:4LZX"
FT   STRAND          61..65
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   HELIX           66..93
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   STRAND          94..96
FT                   /evidence="ECO:0007829|PDB:1WRZ"
FT   STRAND          97..101
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   HELIX           103..112
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   STRAND          113..115
FT                   /evidence="ECO:0007829|PDB:4LZX"
FT   HELIX           119..129
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:4DCK"
FT   STRAND          133..138
FT                   /evidence="ECO:0007829|PDB:4DJC"
FT   HELIX           139..146
FT                   /evidence="ECO:0007829|PDB:4DJC"
SQ   SEQUENCE   149 AA;  16838 MW;  6B4BC3FCDE10727B CRC64;
     MADQLTEEQI AEFKEAFSLF DKDGDGTITT KELGTVMRSL GQNPTEAELQ DMINEVDADG
     NGTIDFPEFL TMMARKMKDT DSEEEIREAF RVFDKDGNGY ISAAELRHVM TNLGEKLTDE
     EVDEMIREAD IDGDGQVNYE EFVQMMTAK
//
